Signaturefd, LLC Albireo Pharma, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$18.01 - $23.78 $5,961 - $7,871	-331 Reduced 46.16%	386 $8,000
Q3 2022 Nov 08, 2022	BUY	$16.32 - $26.37 $10,754 - $17,377	659 Added 1136.21%	717 $14,000
Q2 2022 Aug 10, 2022	BUY	$18.54 - $37.29 $1,075 - $2,162	58 New	58 $1,000
Q4 2021 Jan 25, 2022	SELL	$21.19 - $31.29 $699 - $1,032	-33 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$14.82 - $29.92 $489 - $987	33 New	33 $1,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.